5h agoSeeking AlphaBULLISH 67Analyst
LifeStance Health gains as Hedgeye adds as new long idea
LifeStance Health (LFST) jumps on Hedgeye long call: 32–60% upside backed by revenue/EBITDA forecasts, Q2 beat and FY26 raise—read the thesis.
Archived explainer. For the current picture see today's LFST page.
Why Is LIFESTANCE HEALTH GR (LFST) Stock Up Today?
By the Top Tier Newswire AI Desk · August 10, 2026 at 11:48 AM ET · reviewed against 1 wire stories
LIFESTANCE HEALTH GR (LFST) is up +13.10% in the latest session. Our newswire has captured 1 story on LFST across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 67/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
LifeStance Health (LFST) surged 13.10% to $12.26 on June 30, driven by Hedgeye naming the stock a new long idea with a projected 32, 60% upside. The firm cited strong revenue and EBITDA forecasts, a Q2 earnings beat, and a raised FY2026 sales outlook as key factors. The stock’s intraday performance reflected strong buying pressure, with a high of $12.43 at 11:00 AM ET and a volume of 5.9 million shares, 1.4 times the 3-month average.
What Happened
Hedgeye’s endorsement of LifeStance as a long-term investment triggered a sharp rise in the stock. The firm highlighted the company’s recent financial performance, including a Q2 earnings beat and a raised full-year sales forecast. These developments reinforced investor confidence in the stock’s potential. Additionally, BTIG recently raised its price target to $16 and maintained a Buy rating, further supporting the positive momentum. The company also announced Q3 sales guidance of $420 million to $440 million, exceeding the $418.474 million estimate. These fundamentals contributed to the stock’s strong performance.
What The Data Shows
The stock opened at $10.83 and climbed steadily throughout the session, reaching a high of $12.43 before closing near that level at $12.27. The volume of 5.9 million shares was significantly higher than the 3-month daily average, indicating strong institutional or retail interest. LifeStance has a market cap of $4.1 billion, a P/E ratio of 84.1, and a trailing twelve-month revenue growth of 20.4%. The stock remains within its 52-week range of $3.81 to $11.76, suggesting the move is a sharp but not yet historic reversal. Recent insider transactions show six sales totaling $290.4 million in the last 90 days, with the most recent filing on June 30.
What To Watch
Investors should monitor the company’s Q3 performance against its $420 million to $440 million sales guidance. The stock’s elevated volume and positive coverage suggest continued interest, and any further updates on guidance or earnings could influence its trajectory.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LFST by the numbers
Last: $12.26Session: +13.10%Coverage: 1 stories / 1 sourcesAI sentiment: 67/100 (bullish)Mkt cap: $4.1BP/E: 84.152w: $3.81 to $11.76
The headlines behind the move
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on LFST: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier LFST move explainers: 2026-08-10